Advertisement
Advertisement
VRDN
Viridian Therapeutics, Inc. Common Stock
31.25
USDSponsored
+0.39
+1.26%
Nov 11, 16:00 UTC -5
Closed
Pre-Market
30.30
-0.95
-3.05%
Viridian Therapeutics, Inc. Common Stock (VRDN)
Viridian Therapeutics, Inc. Common Stock Financial Snapshot
| Market Cap | 3.44B |
| Beta | 1.07 |
| Earnings Per Share (EPS) | -3.84 |
| Price-to-Book (P/B) Ratio | 7.09 |
| Operating Margin | -1620.79% |
| Total Debt/Equity (D/E) | 36.57% |
| P/E Ratio | -- |
| Return on Equity (ROE) | -79.67% |
| Current Ratio | 16.95% |
| Free Cash Flow | -226.31M |